# The Role of Islet GLP-1 in the Pathogenesis of Prediabetes

> **NCT06967558** · PHASE2 · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 60 (estimated)

## Conditions studied

- PreDiabetes

## Interventions

- **BIOLOGICAL:** Exendin 9-39
- **BIOLOGICAL:** Saline

## Key facts

- **NCT ID:** NCT06967558
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-01
- **Primary completion:** 2027-10-30
- **Final completion:** 2028-03-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06967558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06967558, "The Role of Islet GLP-1 in the Pathogenesis of Prediabetes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06967558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*